Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion. Tch Vct Regulatory News (AATG)

Share Price Information for Albion. Tch Vct (AATG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 67.50
Ask: 70.50
Change: 0.00 (0.00%)
Spread: 3.00 (4.444%)
Open: 69.00
High: 69.00
Low: 69.00
Prev. Close: 69.00
AATG Live PriceLast checked at -
Albion Technology & General VCT is an Investment Trust

To provide investors with a regular dividend income, combined with the prospect of long-term capital growth, through a balanced portfolio of unquoted growth and technology businesses in a qualifying VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Albion Technology & General VCT PLC - Ordinary Shares : Interim Management Statement

4 Jun 2019 10:29



Albion Technology & General VCT PLC - Ordinary Shares : Interim Management Statement

Albion Technology & General VCT PLC Interim Management StatementLEI code: 213800TKJUY376H3KN16

IntroductionI am pleased to present Albion Technology & General VCT PLC (the “Company”)’s interim management statement for the period from 1 January 2019 to 31 March 2019.

Performance and dividendsThe Company’s unaudited net asset value (NAV) as at 31 March 2019 was £80.3 million or 78.6 pence per share (excluding treasury shares), an increase of 1.2 pence per share or 1.6 per cent. since 31 December 2018.

Share buy-backsDuring the period from 1 January 2019 to 31 March 2019, the Company purchased 993,000 shares for £736,000 including stamp duty, at an average price of 73.73 pence per share. All of the shares are to be held in treasury.

It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders. It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to the most recently announced net asset value, so far as market conditions and liquidity permit.

PortfolioThe following material investment has been made during the period from 1 January 2019 to 31 March 2019:

New investment£000sActivity
Avora Limited400Developer of software to improve decision making through augmented analytics & machine learning

Top ten holdings as at 31 March 2019:

InvestmentCarrying value£’000% of net asset valueActivity
Radnor House School (Holdings) Limited11,45214.3Independent schools for children aged 5-18
Process Systems Enterprise Limited5,3356.6Process modelling software and services
Chonais River Hydro Limited4,1665.2Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands
Bravo Inns II Limited3,4794.3Owner and operator of freehold pubs
Mirada Medical Limited3,2624.1Developer of medical imaging software using Deep Learning
Quantexa Limited3,2024.0Network analytics platform to detect financial crime
Earnside Energy Limited2,5263.1Anaerobic digestion and composting plant located in Scotland
Proveca Limited2,2902.9Reformulation of medicines for paediatric use
G.Network Communications Limited2,2712.8Ultra-fast fibre optic broadband provider in central London
Gharagain River Hydro Limited2,1972.7Owner and operator of a 1 MW hydroelectricity plant in the Scottish Highlands

A full breakdown of the Company’s portfolio can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AATG, by following the ‘Portfolio of Investments’ link under the ‘Fund reports’ section.

Material events and transactions after the period end

PortfolioAfter the period end, the Company undertook the following transactions:

Disposal of Earnside Energy for £2.5 million;Investment of £455,000 in an existing portfolio company, Proveca, which develops drugs specifically formulated for children;Investment of £380,000 in a new portfolio company, Limitless Technology, which provides a customer service platform powered by crowd and machine learning technology; andInvestment of £151,000 in a new portfolio company, Imandra, which provides automated software testing and an enhanced learning experience for artificial neural networks.

Albion VCTs prospectus Top Up OffersThe Board announced on 5 April 2019 that the Company had reached its £8 million limit under its offer pursuant to the Prospectus dated 7 January 2019, and so was closed. The proceeds of the Offer will be used to provide further resources at a time when a number of attractive investment opportunities are being seen.

The following new Ordinary shares of nominal value 1 penny per share were allotted under the Albion VCTs prospectus Top Up Offers 2018/19 after 31 March 2019:

Date of allotmentNumber of shares issuedAggregate nominal value of shares £’000Issue price per share (including costs of issue)Net proceeds £’000
1 April 2019 7,904,5077978.6p to 79.4p6,120
5 April 2019 1,795,8021879.4p1,390
12 April 2019 379,988478.6p to 79.4p294
Total  10,080,297 101 7,804

Material events and transactionsThere have been no further significant events or transactions between 1 April 2019 and 4 June 2019 that the Board is aware of which would have had a material impact on the financial position of the Company.

Further informationFurther information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AATG.

Dr. Neil Cross, Chairman4 June 2019For further information please contact:Albion Capital Group LLP – tel: 020 7601 1850


Date   Source Headline
18th Apr 20083:35 pmRNSFinal Results
31st Mar 20084:55 pmRNSTotal Voting Rights
29th Feb 20085:05 pmRNSTotal Voting Rights
31st Jan 20084:38 pmRNSTotal Voting Rights
2nd Jan 20085:13 pmRNSTotal Voting Rights
17th Dec 20075:36 pmRNSTransaction in Own Shares
10th Dec 20073:50 pmRNSNet Asset Value(s)
30th Nov 20074:41 pmRNSTotal Voting Rights
31st Oct 20074:06 pmRNSTotal Voting Rights
12th Oct 20072:24 pmRNSFSA document viewing facility
1st Oct 200711:58 amRNSTotal Voting Rights
26th Sep 20075:43 pmRNSInterim Results
3rd Sep 20075:28 pmRNSTotal Voting Rights
1st Aug 20073:21 pmRNSTotal Voting Rights
2nd Jul 200712:44 pmRNSTotal Voting Rights
15th Jun 200712:01 pmRNSTransaction in Own Shares
15th Jun 200711:23 amRNSNet Asset Value(s)
12th Jun 200711:26 amRNSDirector/PDMR Shareholding
1st Jun 20079:29 amRNSTotal Voting Rights
18th May 20072:35 pmRNSDoc re Annual Report
18th May 20072:24 pmRNSAnnual Information Update
11th May 20075:10 pmRNSTransaction in Own Shares
1st May 20073:17 pmRNSVoting rights and capital
20th Apr 20076:27 pmRNSFinal Results
2nd Apr 20079:34 amRNSVoting Rights and Capital
1st Feb 20074:01 pmRNSVoting rights and capital
22nd Dec 20061:00 pmRNSVoting Rights & Capital
21st Dec 20061:56 pmRNSNet Asset Value(s)
16th Oct 20063:27 pmRNSFSA Document Viewing Facility
27th Sep 20062:22 pmRNSTransaction in Own Shares
26th Sep 20063:34 pmRNSInterim Results
13th Sep 200612:25 pmRNSDirector Declaration
20th Jun 20063:36 pmRNSAnnual Information Update
16th Jun 20064:15 pmRNSTransaction in Own Shares
6th Jun 20063:53 pmRNSTransaction in Own Shares
26th May 20064:26 pmRNSTransaction in Own Shares
15th May 20063:48 pmRNSDirector/PDMR Shareholding
15th May 20063:41 pmRNSTransaction in Own Shares
11th May 20064:21 pmRNSDoc re. Rep & Fin statements
8th May 20062:54 pmRNSNet Asset Value(s)
26th Apr 20064:34 pmRNSDirector/PDMR Shareholding
13th Apr 20063:00 pmRNSFinal Results
5th Apr 200612:52 pmRNSDirector/PDMR Shareholding
3rd Apr 20062:22 pmRNSIssue of Equity
31st Mar 20062:55 pmRNSIssue of Equity
24th Mar 20061:36 pmRNSOffer for subscription
3rd Mar 20063:29 pmRNSIssue of Equity
9th Feb 200610:01 amRNSDirector/PDMR Shareholding
3rd Feb 20064:25 pmRNSIssue of Equity
3rd Jan 20062:54 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.